CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo.
Haas KM, Sen S, Sanford IG, Miller AS, Poe JC, Tedder TF. CD22 ligand binding regulates normal and malignant B lymphocyte survival in vivo. J Immunol. 2006 Sep 01; 177(5):3063-73.